A BAFF higher serum concentration was found in MS patients negative to BOLF1 compared to MS patients positive to BOLF1 under MP treatment (Dunn’s multiple comparison test, p = 0.024, Fig. 3D). The gene discussed is TNFSF13B; the disease is myeloid sarcoma.